Thierry Naas - Publications

Affiliations: 
Université Paris-Saclay, Gif-sur-Yvette, Île-de-France, France 

257 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Emeraud C, Mahamat A, Jousset AB, Bernabeu S, Goncalves T, Pommier C, Girlich D, Birer A, Rodriguez C, Pawlotsky JM, Naas T, Bonnin RA, Dortet L. Emergence and rapid dissemination of highly resistant NDM-14-producing ST147, France, 2022. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 28. PMID 37855905 DOI: 10.2807/1560-7917.ES.2023.28.42.2300095  0.364
2023 Denakpo E, Naas T, Iorga BI. An updated patent review of metallo-β-lactamase inhibitors (2020-2023). Expert Opinion On Therapeutic Patents. 33: 523-538. PMID 37737836 DOI: 10.1080/13543776.2023.2262763  0.656
2023 Gaillot S, Oueslati S, Vuillemenot JB, Bour M, Iorga BI, Triponney P, Plésiat P, Bonnin RA, Naas T, Jeannot K, Potron A. Genomic characterization of an NDM-9-producing clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Frontiers in Microbiology. 14: 1253160. PMID 37700870 DOI: 10.3389/fmicb.2023.1253160  0.628
2023 Rima M, Pfennigwerth N, Cremanns M, Cirnski K, Oueslati S, Gatermann SG, d'Amélio N, Herrmann J, Müller R, Naas T. In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics (Basel, Switzerland). 12. PMID 37627685 DOI: 10.3390/antibiotics12081265  0.318
2023 Jousset AB, Bouabdallah L, Birer A, Rosinski-Chupin I, Mariet JF, Oueslati S, Emeraud C, Girlich D, Glaser P, Naas T, Bonnin RA, Dortet L. Population Analysis of Escherichia coli Sequence Type 361 and Reduced Cefiderocol Susceptibility, France. Emerging Infectious Diseases. 29: 1877-1881. PMID 37610183 DOI: 10.3201/eid2909.230390  0.369
2023 Kassem II, Osman M, Hassan J, Sulaiman A, Mann D, Esseili MA, Naas T, Deng X. First Report of the Mobile Colistin Resistance Gene, mcr-1.26, in Multidrug-Resistant Escherichia coli Isolated from Retail Chicken Meat. Journal of Global Antimicrobial Resistance. PMID 37429544 DOI: 10.1016/j.jgar.2023.07.005  0.364
2023 Naas T, Dabos L, Bonnin RA. β-Lactamase Genes without Limits. Microorganisms. 11. PMID 37317173 DOI: 10.3390/microorganisms11051200  0.336
2023 Bonnin RA, Bernabeu S, Emeraud C, Naas T, Girlich D, Jousset AB, Dortet L. In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales. Antibiotics (Basel, Switzerland). 12. PMID 36671303 DOI: 10.3390/antibiotics12010102  0.346
2023 Dabos L, Raczynska JE, Bogaerts P, Zavala A, Girlich D, Bonnin RA, Dortet L, Peyrat A, Retailleau P, Iorga BI, Jaskólski M, Glupczynski Y, Naas T. Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. Antimicrobial Agents and Chemotherapy. e0109522. PMID 36648230 DOI: 10.1128/aac.01095-22  0.819
2022 Oueslati S, Bogaerts P, Dortet L, Bernabeu S, Ben Lakhal H, Longshaw C, Glupczynski Y, Naas T. In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium. Antibiotics (Basel, Switzerland). 11. PMID 36290010 DOI: 10.3390/antibiotics11101352  0.319
2022 Rima M, Oueslati S, Dabos L, Daaboul D, Mallat H, Bou Raad E, Achkar M, Mawlawi O, Bernabeu S, Bonnin RA, Girlich D, Osman M, Hamze M, Naas T. Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon. Antibiotics (Basel, Switzerland). 11. PMID 36289953 DOI: 10.3390/antibiotics11101295  0.319
2022 Dahdouh E, Allander L, Falgenhauer L, Iorga BI, Lorenzetti S, Marcos-Alcalde Í, Martin NI, Martínez-Martínez L, Mingorance J, Naas T, Rubin JE, Spyrakis F, Tängdén T, Gómez-Puertas P. Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network. International Journal of Molecular Sciences. 23. PMID 36077146 DOI: 10.3390/ijms23179746  0.479
2022 Bonnin RA, Bernabeu S, Emeraud C, Creton E, Vanparis O, Naas T, Jousset AB, Dortet L. Susceptibility of OXA-48-producing Enterobacterales to imipenem/relebactam, meropenem/vaborbactam and ceftazidime/avibactam. International Journal of Antimicrobial Agents. 60: 106660. PMID 35988666 DOI: 10.1016/j.ijantimicag.2022.106660  0.334
2022 Muntean MM, Muntean AA, Guerin F, Cattoir V, Creton E, Cotellon G, Oueslati S, Popa MI, Girlich D, Iorga BI, Bonnin RA, Naas T. Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response. The Journal of Antimicrobial Chemotherapy. PMID 35199171 DOI: 10.1093/jac/dkac058  0.466
2022 Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Zongo PD, Héry M, Oueslati S, Girlich D, Dortet L, Bonnin RA, Naas T, Glaser P. Specificities and Commonalities of Carbapenemase-Producing Escherichia coli Isolated in France from 2012 to 2015. Msystems. e0116921. PMID 35014866 DOI: 10.1128/msystems.01169-21  0.382
2021 Girlich D, Bonnin RA, Proust A, Naas T, Dortet L. Undetectable Production of the VIM-1 Carbapenemase in an Clinical Isolate. Frontiers in Microbiology. 12: 741972. PMID 34987484 DOI: 10.3389/fmicb.2021.741972  0.321
2021 Jousset AB, Oueslati S, Emeraud C, Bonnin RA, Dortet L, Iorga BI, Naas T. KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate. Antimicrobial Agents and Chemotherapy. 65: e0116021. PMID 34606331 DOI: 10.1128/AAC.01160-21  0.615
2021 de Barsy M, Mercuri PS, Oueslati S, Elisée E, Huang TD, Sacré P, Iorga BI, Naas T, Galleni M, Bogaerts P. Detection and characterization of VIM-52, a new variant of VIM-1 from clinical isolate. Antimicrobial Agents and Chemotherapy. AAC0266020. PMID 34370584 DOI: 10.1128/AAC.02660-20  0.641
2021 Moguet C, Gonzalez C, Sallustrau A, Gelhaye S, Naas T, Simon S, Volland H. Detection of expanded-spectrum cephalosporin hydrolysis by lateral flow immunoassay. Microbial Biotechnology. PMID 34342151 DOI: 10.1111/1751-7915.13892  0.334
2021 Muntean MM, Muntean AA, Guerin F, Cattoir V, Creton E, Cotellon G, Oueslati S, Popa MI, Girlich D, Iorga BI, Bonnin RA, Naas T. Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers. The Journal of Antimicrobial Chemotherapy. PMID 34143889 DOI: 10.1093/jac/dkab170  0.493
2021 Rima M, Emeraud C, Bonnin RA, Gonzalez C, Dortet L, Iorga BI, Oueslati S, Naas T. Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity. The Journal of Antimicrobial Chemotherapy. PMID 33993262 DOI: 10.1093/jac/dkab142  0.603
2021 Romero E, Oueslati S, Benchekroun M, D'Hollander ACA, Ventre S, Vijayakumar K, Minard C, Exilie C, Tlili L, Retailleau P, Zavala A, Elisée E, Selwa E, Nguyen LA, Pruvost A, ... Naas T, et al. Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). European Journal of Medicinal Chemistry. 219: 113418. PMID 33862516 DOI: 10.1016/j.ejmech.2021.113418  0.818
2021 Çekin ZK, Dabos L, Malkoçoğlu G, Fortineau N, Bayraktar B, Iorga BI, Naas T, Aktaş E. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital. Diagnostic Microbiology and Infectious Disease. 99: 115174. PMID 32980808 DOI: 10.1016/J.Diagmicrobio.2020.115174  0.664
2020 Bonnin RA, Jousset AB, Emeraud C, Oueslati S, Dortet L, Naas T. Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales. Frontiers in Medicine. 7: 616490. PMID 33553210 DOI: 10.3389/fmed.2020.616490  0.363
2020 Bonnin RA, Girlich D, Jousset AB, Gauthier L, Cuzon G, Bogaerts P, Haenni M, Madec JY, Couvé-Deacon E, Barraud O, Fortineau N, Glaser P, Glupczynski Y, Dortet L, Naas T. A single Proteus mirabilis lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in Enterobacterales. Scientific Reports. 10: 9160. PMID 32514057 DOI: 10.1038/S41598-020-66161-Z  0.399
2020 Bonnin RA, Jousset AB, Chiarelli A, Emeraud C, Glaser P, Naas T, Dortet L. Emergence of New Non-Clonal Group 258 High-Risk Clones among Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Isolates, France. Emerging Infectious Diseases. 26: 1212-1220. PMID 32441629 DOI: 10.3201/Eid2606.191517  0.392
2020 Girlich D, Bogaerts P, Bouchahrouf W, Bernabeu S, Langlois I, Begasse C, Arangia N, Dortet L, Huang TD, Glupczynski Y, Naas T. Evaluation of the Novodiag CarbaR+, a Novel Integrated Sample to Result Platform for the Multiplex Qualitative Detection of Carbapenem and Colistin Resistance Markers. Microbial Drug Resistance (Larchmont, N.Y.). PMID 32429736 DOI: 10.1089/Mdr.2020.0132  0.39
2020 Rivière G, Oueslati S, Gayral M, Créchet JB, Nhiri N, Jacquet E, Cintrat JC, Giraud F, van Heijenoort C, Lescop E, Pethe S, Iorga BI, Naas T, Guittet E, Morellet N. NMR Characterization of the Influence of Zinc(II) Ions on the Structural and Dynamic Behavior of the New Delhi Metallo-β-Lactamase-1 and on the Binding with Flavonols as Inhibitors. Acs Omega. 5: 10466-10480. PMID 32426604 DOI: 10.1021/acsomega.0c00590  0.588
2020 Jousset AB, Bonnin RA, Takissian J, Girlich D, Mihaila L, Cabanel N, Dortet L, Glaser P, Naas T. Concomitant carriage of KPC-producing and non-KPC-producing Klebsiella pneumoniae ST512 within a single patient. The Journal of Antimicrobial Chemotherapy. PMID 32386410 DOI: 10.1093/Jac/Dkaa137  0.318
2020 Emeraud C, Biez L, Girlich D, Jousset AB, Naas T, Bonnin RA, Dortet L. Screening of OXA-244 producers, a difficult-to-detect and emerging OXA-48 variant? The Journal of Antimicrobial Chemotherapy. 75: 2120-2123. PMID 32363407 DOI: 10.1093/Jac/Dkaa155  0.322
2020 Dabos L, Zavala A, Bonnin RA, Beckstein O, Retailleau P, Iorga BI, Naas T. Substrate Specificity of OXA-48 after β5-β6 Loop Replacement. Acs Infectious Diseases. 6: 1032-1043. PMID 32156115 DOI: 10.1021/Acsinfecdis.9B00452  0.799
2020 Girlich D, Bonnin RA, Dortet L, Naas T. Genetics of Acquired Antibiotic Resistance Genes in spp. Frontiers in Microbiology. 11: 256. PMID 32153540 DOI: 10.3389/Fmicb.2020.00256  0.48
2020 Oueslati S, Retailleau P, Marchini L, Berthault C, Dortet L, Bonnin RA, Iorga BI, Naas T. Role of Arginine 214 in the Substrate Specificity of OXA-48. Antimicrobial Agents and Chemotherapy. 64. PMID 32071047 DOI: 10.1128/Aac.02329-19  0.593
2020 Bonnin RA, Bernabeu S, Jaureguy F, Naas T, Dortet L. MCR-8 mediated colistin resistance in a carbapenem-resistant Klebsiella pneumoniae isolated from a repatriated patient from Morocco. International Journal of Antimicrobial Agents. 55: 105920. PMID 32062001 DOI: 10.1016/J.Ijantimicag.2020.105920  0.424
2020 Girlich D, Laguide M, Dortet L, Naas T. Evaluation of the Revogene® Carba C Assay for detection and differentiation of carbapenemase-producing Gram negative bacteria. Journal of Clinical Microbiology. PMID 31996448 DOI: 10.1128/Jcm.01927-19  0.352
2020 Patiño-Navarrete R, Rosinski-Chupin I, Cabanel N, Gauthier L, Takissian J, Madec JY, Hamze M, Bonnin RA, Naas T, Glaser P. Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli. Genome Medicine. 12: 10. PMID 31955713 DOI: 10.1186/S13073-019-0699-6  0.431
2020 Bonnin RA, Jousset AB, Gauthier L, Emeraud C, Girlich D, Sauvadet A, Cotellon G, Jové T, Dortet L, Naas T. First occurrence of the OXA-198 carbapenemase in Enterobacterales. Antimicrobial Agents and Chemotherapy. PMID 31932369 DOI: 10.1128/Aac.01471-19  0.464
2020 Rodríguez-Villodres Á, Gil-Marqués ML, Álvarez-Marín R, Bonnin RA, Pachón-Ibáñez ME, Aguilar-Guisado M, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli. The Journal of Antimicrobial Chemotherapy. 75: 77-85. PMID 31613964 DOI: 10.1093/Jac/Dkz393  0.497
2019 Oueslati S, Retailleau P, Marchini L, Dortet L, Bonnin RA, Iorga BI, Naas T. Biochemical and Structural Characterization of OXA-405, an OXA-48 Variant with Extended-Spectrum β-Lactamase Activity. Microorganisms. 8. PMID 31877796 DOI: 10.3390/microorganisms8010024  0.623
2019 Oueslati S, Tlili L, Exilie C, Bernabeu S, Iorga B, Bonnin RA, Dortet L, Naas T. Different phenotypic expression of KPC β-lactamase variants and challenges in their detection. The Journal of Antimicrobial Chemotherapy. PMID 31848599 DOI: 10.1093/Jac/Dkz508  0.631
2019 Rodríguez-Villodres Á, Bonnin RA, Ortiz de la Rosa JM, Álvarez-Marín R, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y. Phylogeny, Resistome, and Virulome of Causing Biliary Tract Infections. Journal of Clinical Medicine. 8. PMID 31810308 DOI: 10.3390/Jcm8122118  0.38
2019 Dabos L, Rodriguez CH, Nastro M, Dortet L, Bonnin R, Famiglietti A, Iorga BI, Vay C, Naas T. LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs. International Journal of Antimicrobial Agents. PMID 31785341 DOI: 10.1016/J.Ijantimicag.2019.11.014  0.697
2019 Girlich D, Oueslati S, Bernabeu S, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Fortineau N, Naas T. Evaluation of the BD MAX Check-Points CPO Assay for the Detection of Carbapenemase Producers Directly from Rectal Swabs. The Journal of Molecular Diagnostics : Jmd. PMID 31751674 DOI: 10.1016/J.Jmoldx.2019.10.004  0.31
2019 Boulant T, Jousset AB, Bonnin RA, Barrail-Tran A, Borgel A, Oueslati S, Naas T, Dortet L. A 2.5-years within-patient evolution of a with acquisition of ceftolozane-tazobactam and ceftazidime-avibactam resistance upon treatment. Antimicrobial Agents and Chemotherapy. PMID 31636072 DOI: 10.1128/Aac.01637-19  0.436
2019 Dortet L, Broda A, Bernabeu S, Glupczynski Y, Bogaerts P, Bonnin R, Naas T, Filloux A, Larrouy-Maumus G. Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS. The Journal of Antimicrobial Chemotherapy. PMID 31580426 DOI: 10.1093/Jac/Dkz405  0.412
2019 Nadimpalli ML, de Lauzanne A, Phe T, Borand L, Jacobs J, Fabre L, Naas T, Le Hello S, Stegger M. Escherichia coli ST410 among humans and the environment in Southeast Asia. International Journal of Antimicrobial Agents. 54: 228-232. PMID 31176748 DOI: 10.1016/J.Ijantimicag.2019.05.024  0.394
2019 Girlich D, Grosperrin V, Naas T, Dortet L. CHROMagar™ ESBL/mSuperCARBA bi-plate medium for detection of ESBL- and carbapenemase-producing Enterobacteriaceae from spiked stools. Diagnostic Microbiology and Infectious Disease. 95: 107-112. PMID 31171396 DOI: 10.1016/J.Diagmicrobio.2019.05.002  0.302
2019 Oueslati S, Iorga BI, Tlili L, Exilie C, Zavala A, Dortet L, Jousset AB, Bernabeu S, Bonnin RA, Naas T. Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity. The Journal of Antimicrobial Chemotherapy. 74: 2239-2246. PMID 31127297 DOI: 10.1093/Jac/Dkz209  0.787
2019 Dabos L, Patiño-Navarrete R, Nastro M, Famiglietti A, Glaser P, Rodriguez CH, Naas T. SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogeny. The Journal of Antimicrobial Chemotherapy. PMID 30993333 DOI: 10.1093/Jac/Dkz115  0.34
2019 Emeraud C, Escaut L, Boucly A, Fortineau N, Bonnin RA, Naas T, Dortet L. Aztreonam plus Clavulanate, Tazobactam, or Avibactam for Treatment of Infections Caused by Metallo-β-Lactamase-Producing Gram-Negative Bacteria. Antimicrobial Agents and Chemotherapy. 63. PMID 30858212 DOI: 10.1128/Aac.00010-19  0.46
2019 Volland H, Dortet L, Bernabeu S, Boutal H, Haenni M, Madec JY, Robin F, Beyrouthy R, Naas T, Simon S. Development and multicentric validation of a lateral flow immunoassay for the rapid detection of MCR-1-producing . Journal of Clinical Microbiology. PMID 30842227 DOI: 10.1128/Jcm.01454-18  0.431
2019 Zavala A, Retailleau P, Elisée E, Iorga BI, Naas T. Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant. Acs Infectious Diseases. 5: 528-538. PMID 30788955 DOI: 10.1021/Acsinfecdis.8B00240  0.823
2019 Jousset AB, Oueslati S, Bernabeu S, Takissian J, Creton E, Vogel A, Sauvadet A, Cotellon G, Gauthier L, Bonnin RA, Dortet L, Naas T. False-positive carbapenem-hydrolyzing confirmatory tests due to ACT-28, a chromosomally-encoded AmpC with weak carbapenemase activity from . Antimicrobial Agents and Chemotherapy. PMID 30783006 DOI: 10.1128/Aac.02388-18  0.469
2019 Nadimpalli M, Vuthy Y, de Lauzanne A, Fabre L, Criscuolo A, Gouali M, Huynh BT, Naas T, Phe T, Borand L, Jacobs J, Kerléguer A, Piola P, Guillemot D, Le Hello S, et al. Meat and Fish as Sources of Extended-Spectrum β-Lactamase-Producing Escherichia coli, Cambodia. Emerging Infectious Diseases. 25. PMID 30561323 DOI: 10.3201/Eid2501.180534  0.467
2019 Girlich D, Bernabeu S, Grosperrin V, Langlois I, Begasse C, Arangia N, Creton E, Cotellon G, Sauvadet A, Dortet L, Naas T. Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria. Journal of Clinical Microbiology. 57. PMID 30541941 DOI: 10.1128/Jcm.01800-18  0.402
2019 Jousset AB, Bernabeu S, Bonnin RA, Creton E, Cotellon G, Sauvadet A, Naas T, Dortet L. Development and validation of a multiplex polymerase chain reaction assay for detection of the five families of plasmid-encoded colistin resistance. International Journal of Antimicrobial Agents. 53: 302-309. PMID 30395987 DOI: 10.1016/J.Ijantimicag.2018.10.022  0.456
2019 Girlich D, Naas T, Dortet L. Comparison of the Superpolymyxin and ChromID Colistin R Screening Media for the Detection of Colistin-Resistant from Spiked Rectal Swabs. Antimicrobial Agents and Chemotherapy. 63. PMID 30323032 DOI: 10.1128/Aac.01618-18  0.395
2019 Dabos L, Zavala A, Bonnin RA, Beckstein O, Retailleau P, Iorga BI, Naas T. Crystal Structure of Rationally Designed OXA-48loop18 beta-lactamase Acs Infectious Diseases. DOI: 10.2210/Pdb6Hoo/Pdb  0.764
2018 Jousset AB, Rosinski-Chupin I, Takissian J, Glaser P, Bonnin RA, Naas T. Transcriptional Landscape of a Plasmid and Response to Imipenem Exposure in TOP10. Frontiers in Microbiology. 9: 2929. PMID 30559731 DOI: 10.3389/Fmicb.2018.02929  0.388
2018 Dortet L, Potron A, Bonnin RA, Plesiat P, Naas T, Filloux A, Larrouy-Maumus G. Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria. Scientific Reports. 8: 16910. PMID 30442963 DOI: 10.1038/S41598-018-35041-Y  0.451
2018 Boulant T, Boudehen YM, Filloux A, Plesiat P, Naas T, Dortet L. Higher Prevalence of PldA, a -Kingdom H2-Type VI Secretion System Effector, in Clinical Isolates Responsible for Acute Infections and in Multidrug Resistant Strains. Frontiers in Microbiology. 9: 2578. PMID 30420847 DOI: 10.3389/Fmicb.2018.02578  0.369
2018 Gauthier L, Dortet L, Jousset AB, Mihaila L, Golse N, Naas T, Bonnin RA. Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae. The Journal of Antimicrobial Chemotherapy. PMID 30252055 DOI: 10.1093/Jac/Dky372  0.395
2018 Dortet L, Bonnin RA, Pennisi I, Gauthier L, Jousset AB, Dabos L, Furniss RCD, Mavridou DAI, Bogaerts P, Glupczynski Y, Potron A, Plesiat P, Beyrouthy R, Robin F, Bonnet R, ... Naas T, et al. Rapid detection and discrimination of chromosome- and MCR-plasmid-mediated resistance to polymyxins by MALDI-TOF MS in Escherichia coli: the MALDIxin test. The Journal of Antimicrobial Chemotherapy. PMID 30184212 DOI: 10.1093/Jac/Dky330  0.436
2018 Dabos L, Jousset AB, Bonnin RA, Fortineau N, Zavala A, Retailleau P, Iorga BI, Naas T. Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase. Antimicrobial Agents and Chemotherapy. 62. PMID 30082287 DOI: 10.1128/Aac.01198-18  0.795
2018 Angers-Loustau A, Petrillo M, Bengtsson-Palme J, Berendonk T, Blais B, Chan KG, Coque TM, Hammer P, Heß S, Kagkli DM, Krumbiegel C, Lanza VF, Madec JY, Naas T, O'Grady J, et al. The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies. F1000research. 7: 459. PMID 30026930 DOI: 10.12688/f1000research.14509.2  0.346
2018 Girlich D, Bernabeu S, Fortineau N, Dortet L, Naas T. Evaluation of the CRE and ESBL ELITe MGB® kits for the accurate detection of carbapenemase- or CTX-M-producing bacteria. Diagnostic Microbiology and Infectious Disease. 92: 1-7. PMID 29983286 DOI: 10.1016/J.Diagmicrobio.2018.02.001  0.366
2018 Gauthier L, Dortet L, Cotellon G, Creton E, Cuzon G, Ponties V, Bonnin RA, Naas T. Diversity of carbapenemase-producing isolates, France 2012-2013. Antimicrobial Agents and Chemotherapy. PMID 29866863 DOI: 10.1128/Aac.00266-18  0.393
2018 Rodriguez MM, Ghiglione B, Power P, Naas T, Gutkind G. Proposing as the origin of the plasmid-mediated resistance gene . Antimicrobial Agents and Chemotherapy. PMID 29866858 DOI: 10.1128/Aac.00710-18  0.429
2018 Dabos L, Bogaerts P, Bonnin RA, Zavala A, Sacré P, Iorga BI, Huang DT, Glupczynski Y, Naas T. Genetic and Biochemical characterization of OXA-519, a novel OXA-48-like β-lactamase. Antimicrobial Agents and Chemotherapy. PMID 29866857 DOI: 10.1128/Aac.00469-18  0.826
2018 Jaidane N, Naas T, Oueslati S, Bernabeu S, Boujaafar N, Bouallegue O, Bonnin RA. Whole-genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii isolates from Tunisia. International Journal of Antimicrobial Agents. 52: 916-921. PMID 29857033 DOI: 10.1016/J.Ijantimicag.2018.05.017  0.449
2018 Miltgen G, Bonnin RA, Avril C, Benoit-Cattin T, Martak D, Leclaire A, Traversier N, Roquebert B, Jaffar-Bandjee MC, Lugagne N, Filleul L, Subiros M, de Montera AM, Cholley P, Thouverez M, ... ... Naas T, et al. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean). International Journal of Antimicrobial Agents. 52: 416-420. PMID 29807164 DOI: 10.1016/J.Ijantimicag.2018.05.015  0.497
2018 Leroy AG, Naze F, Dortet L, Naas T, Jaubert J. Plasmid-mediated colistin resistance gene mcr-1 in a clinical Escherichia coli isolate in the Indian Ocean Commission. Medecine Et Maladies Infectieuses. 48: 426-428. PMID 29753527 DOI: 10.1016/j.medmal.2018.04.388  0.333
2018 Jousset AB, Bonnin RA, Rosinski-Chupin I, Girlich D, Cuzon G, Cabanel N, Frech H, Farfour E, Dortet L, Glaser P, Naas T. 4.5 years within-patient evolution of a colistin resistant KPC-producing Klebsiella pneumoniae ST258. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29688339 DOI: 10.1093/Cid/Ciy293  0.377
2018 Bonnin RA, Bogaerts P, Girlich D, Huang DT, Dortet L, Glupczynski Y, Naas T. Molecular characterization of OXA-198 carbapenemase producingclinical isolates. Antimicrobial Agents and Chemotherapy. PMID 29581118 DOI: 10.1128/Aac.02496-17  0.458
2018 Dortet L, Bernabeu S, Gonzalez C, Naas T. Evaluation of the Carbapenem Detection Set™ for the detection and characterization of carbapenemase-producing Enterobacteriaceae. Diagnostic Microbiology and Infectious Disease. PMID 29548525 DOI: 10.1016/J.Diagmicrobio.2018.02.012  0.312
2018 Ruggiero M, Girlich D, Dabos L, Power P, Naas T, Gutkind G. Complete Sequence of the IncA/C Plasmid pCf587 Carrying from Citrobacter freundii. Antimicrobial Agents and Chemotherapy. 62. PMID 29463531 DOI: 10.1128/Aac.00006-18  0.416
2018 Oueslati S, Girlich D, Dortet L, Naas T. Evaluation of the Amplidiag CarbaR+VRE Kit for Accurate Detection of Carbapenemase-Producing Bacteria. Journal of Clinical Microbiology. 56. PMID 29305547 DOI: 10.1128/Jcm.01092-17  0.433
2018 Jaidane N, Bonnin RA, Mansour W, Girlich D, Creton E, Cotellon G, Chaouch C, Boujaafar N, Bouallegue O, Naas T. Genomic Insights into Colistin-Resistant Klebsiella pneumoniae from a Tunisian Teaching Hospital. Antimicrobial Agents and Chemotherapy. 62. PMID 29229634 DOI: 10.1128/Aac.01601-17  0.5
2018 Jaidane N, Naas T, Mansour W, Radhia BB, Jerbi S, Boujaafar N, Bouallegue O, Bonnin RA. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii. International Journal of Antimicrobial Agents. 51: 266-269. PMID 29127051 DOI: 10.1016/J.Ijantimicag.2017.10.016  0.493
2017 B Jousset A, Dortet L, Naas T. [Multidrug resistant bacteria and emerging antibiotic resistance traits]. La Revue Du Praticien. 67: 211-217. PMID 30512860  0.34
2017 Potron A, Bernabeu S, Cuzon G, Pontiès V, Blanchard H, Seringe E, Naas T, Nordmann P, Dortet L. Analysis of OXA-204 carbapenemase-producing Enterobacteriaceae reveals possible endoscopy-associated transmission, France, 2012 to 2014. Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin. 22. PMID 29233256 DOI: 10.2807/1560-7917.Es.2017.22.49.17-00048  0.45
2017 Dortet L, Glaser P, Kassis-Chikhani N, Girlich D, Ichai P, Boudon M, Samuel D, Creton E, Imanci D, Bonnin R, Fortineau N, Naas T. Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France. The Journal of Antimicrobial Chemotherapy. PMID 29092052 DOI: 10.1093/Jac/Dkx370  0.387
2017 Ayari K, Bourouis A, Chihi H, Mahrouki S, Naas T, Belhadj O. Dissemination and genetic support of broad-spectrum beta-lactam-resistant strain isolated from two Tunisian hospitals during 2004-2012. African Health Sciences. 17: 346-355. PMID 29062329 DOI: 10.4314/Ahs.V17I2.8  0.483
2017 Jousset AB, Dabos L, Bonnin RA, Girlich D, Potron A, Cabanel N, Dortet L, Glaser P, Naas T. CTX-M-15-producing Shewanella sp. clinical isolate expressing OXA-535, a chromosome-encoded OXA-48 variant, putative progenitor of the plasmid-encoded OXA-436. Antimicrobial Agents and Chemotherapy. PMID 29038283 DOI: 10.1128/Aac.01879-17  0.443
2017 Bogaerts P, Naas T, Saegeman V, Bonnin RA, Schuermans A, Evrard S, Bouchahrouf W, Jove T, Tande D, de Bolle X, Huang TD, Dortet L, Glupczynski Y. OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae. The Journal of Antimicrobial Chemotherapy. 72: 2469-2477. PMID 28859446 DOI: 10.1093/Jac/Dkx184  0.394
2017 Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI. Beta-lactamase database (BLDB) - structure and function. Journal of Enzyme Inhibition and Medicinal Chemistry. 32: 917-919. PMID 28719998 DOI: 10.1080/14756366.2017.1344235  0.721
2017 Hoyos-Mallecot Y, Naas T, Bonnin RA, Patino R, Glaser P, Fortineau N, Dortet L. OXA-244-producing Escherichia coli isolates: a challenge for clinical microbiology laboratories. Antimicrobial Agents and Chemotherapy. PMID 28674064 DOI: 10.1128/Aac.00818-17  0.4
2017 Beyrouthy R, Robin F, Lessene A, Lacombat I, Dortet L, Naas T, Ponties V, Bonnet R. MCR-1 and OXA-48 in vivo acquisition in KPC-producing Escherichia coli after colistin treatment. Antimicrobial Agents and Chemotherapy. PMID 28507112 DOI: 10.1128/Aac.02540-16  0.421
2017 Riazzo C, López-Cerero L, Rojo-Martín MD, Hoyos-Mallecot Y, Fernández-Cuenca F, Martín-Ruíz JL, Pascual-Hernández Á, Naas T, Navarro-Marí JM. First report of NDM-1-producing clinical isolate of Leclercia adecarboxylata in Spain. Diagnostic Microbiology and Infectious Disease. 88: 268-270. PMID 28506721 DOI: 10.1016/J.Diagmicrobio.2017.04.013  0.419
2017 Boutal H, Naas T, Devilliers K, Oueslati S, Dortet L, Bernabeu S, Simon S, Volland H. Development and validation of a lateral flow immunoassay for the rapid detection of NDM-producing Enterobacteriaceae. Journal of Clinical Microbiology. PMID 28404680 DOI: 10.1128/Jcm.00248-17  0.439
2017 Lahlaoui H, Bonnin RA, Moussa MB, Khelifa ABH, Naas T. First report of OXA-232-producing Klebsiella pneumoniae strains in Tunisia. Diagnostic Microbiology and Infectious Disease. 88: 195-197. PMID 28341097 DOI: 10.1016/J.Diagmicrobio.2017.03.005  0.435
2017 Bernabeu S, Dortet L, Naas T. Evaluation of the β-CARBA™ test, a colorimetric test for the rapid detection of carbapenemase activity in Gram-negative bacilli. The Journal of Antimicrobial Chemotherapy. 72: 1646-1658. PMID 28333363 DOI: 10.1093/Jac/Dkx061  0.354
2017 Girlich D, Bonnin RA, Jousset A, Naas T. Promoter characterization and expression of the blaKPC-2 gene in Escherichia coli, Pseudomonas aeruginosa and Acinetobacter baumannii. The Journal of Antimicrobial Chemotherapy. 72: 1597-1601. PMID 28333348 DOI: 10.1093/Jac/Dkx044  0.363
2017 Dortet L, Naas T. Noncarbapenemase OXA-48 Variants (OXA-163 and OXA-405) Falsely Detected as Carbapenemases by the β Carba Test. Journal of Clinical Microbiology. 55: 654-655. PMID 28122994 DOI: 10.1128/Jcm.02086-16  0.346
2017 Dortet L, Girlich D, Virlouvet AL, Poirel L, Nordmann P, Iorga BI, Naas T. Characterization of BRP, the Bleomycin Resistance Protein Associated with the Carbapenemase NDM. Antimicrobial Agents and Chemotherapy. 61. PMID 28069656 DOI: 10.1128/Aac.02413-16  0.656
2017 Bonnin RA, Jousset AB, Urvoy N, Gauthier L, Tlili L, Creton E, Cotellon G, Arthur F, Dortet L, Naas T. Detection of GES-5 carbapenemase in Klebsiella pneumoniae, a newcomer in France. Antimicrobial Agents and Chemotherapy. PMID 28052846 DOI: 10.1128/Aac.02263-16  0.306
2017 Bonnin RA, Didi J, Ergani A, Lima S, Naas T. Chromosome-Encoded Broad-Spectrum Ambler Class A β-Lactamase RUB-1 from Serratia rubidaea. Antimicrobial Agents and Chemotherapy. 61. PMID 27956418 DOI: 10.1128/Aac.01908-16  0.462
2016 Vila J, Sáez-López E, Johnson JR, Römling U, Dobrindt U, Cantón R, Giske CG, Naas T, Carattoli A, Martínez-Medina M, Bosch J, Retamar P, Rodríguez-Baño J, Baquero F, Soto SM. Escherichia coli: an old friend with new tidings. Fems Microbiology Reviews. 40: 437-463. PMID 28201713 DOI: 10.1093/Femsre/Fuw005  0.38
2016 Ellington MJ, Ekelund O, Aarestrup FM, Canton R, Doumith M, Giske C, Grundman H, Hasman H, Holden MTG, Hopkins KL, Iredell J, Kahlmeter G, Köser CU, MacGowan A, Mevius D, ... ... Naas T, et al. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 23: 2-22. PMID 27890457 DOI: 10.1016/J.Cmi.2016.11.012  0.388
2016 Girlich D, Bonnin RA, Bogaerts P, De Laveleye M, Huang DT, Dortet L, Glaser P, Glupczynski Y, Naas T. Chromosomal amplification of the blaOXA-58 carbapenemase gene in a Proteus mirabilis clinical isolate. Antimicrobial Agents and Chemotherapy. PMID 27855079 DOI: 10.1128/Aac.01697-16  0.441
2016 Cuzon G, Levy M, Jacob E, Dortet L, Naas T. IMI-1-producing Enterobacter cloacae clinical isolate from Tahiti, French Polynesia. Journal of Global Antimicrobial Resistance. 5: 1-2. PMID 27436456 DOI: 10.1016/J.Jgar.2016.01.005  0.318
2016 Dortet L, Bonnin RA, Bernabeu S, Escaut L, Vittecoq D, Girlich D, Imanci D, Fortineau N, Naas T. First Occurrence of OXA-72-Producing Acinetobacter baumannii in Serbia. Antimicrobial Agents and Chemotherapy. 60: 5724-30. PMID 27431216 DOI: 10.1128/Aac.01016-16  0.506
2016 Bogaerts P, Cuzon G, Evrard S, Hoebeke M, Naas T, Glupczynski Y. Evaluation of a DNA microarray for rapid detection of the most prevalent extended-spectrum β-lactamases, plasmid-mediated cephalosporinases and carbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter. International Journal of Antimicrobial Agents. PMID 27374747 DOI: 10.1016/J.Ijantimicag.2016.05.006  0.474
2016 Naas T, Cuzon G, Robinson AL, Andrianirina Z, Imbert P, Ratsima E, Ranosiarisoa ZN, Nordmann P, Raymond J. Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar. Bmc Infectious Diseases. 16: 275. PMID 27287441 DOI: 10.1186/S12879-016-1580-5  0.388
2016 Cuzon G, Bogaerts P, Bauraing C, Huang TD, Bonnin RA, Glupczynski Y, Naas T. Spread of plasmids carrying multiple GES variants. Antimicrobial Agents and Chemotherapy. PMID 27216071 DOI: 10.1128/Aac.00360-16  0.425
2016 Naas T, Dortet L, Iorga BI. Structural and Functional Aspects of Class A Carbapenemases. Current Drug Targets. 17: 1006-28. PMID 26960341 DOI: 10.2174/1389450117666160310144501  0.69
2016 Chihi H, Bonnin RA, Bourouis A, Mahrouki S, Besbes S, Moussa MB, Belhadj O, Naas T. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa Journal of Global Antimicrobial Resistance. 5: 47-50. DOI: 10.1016/J.Jgar.2016.03.005  0.486
2015 Breurec S, Bastian S, Cuzon G, Bernabeu S, Foucan T, Galanth S, Naas T, Dortet L. Emergence of OXA-48-producing Escherichia coli in the Caribbean islands. Journal of Global Antimicrobial Resistance. 3: 217-218. PMID 27873713 DOI: 10.1016/J.Jgar.2015.04.004  0.337
2015 Dortet L, Bonnin RA, Girlich D, Imanci D, Bernabeu S, Fortineau N, Naas T. Whole-Genome Sequence of a European Clone II and OXA-72-Producing Acinetobacter baumannii Strain from Serbia. Genome Announcements. 3. PMID 26659671 DOI: 10.1128/Genomea.01390-15  0.345
2015 Cuzon G, Bentchouala C, Vogel A, Héry M, Lezzar A, Smati F, Dortet L, Naas T. First outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Constantine, Algeria. International Journal of Antimicrobial Agents. PMID 26453148 DOI: 10.1016/J.Ijantimicag.2015.08.005  0.439
2015 Dortet L, Flonta M, Boudehen YM, Creton E, Bernabeu S, Vogel A, Naas T. Dissemination of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa in Romania. Antimicrobial Agents and Chemotherapy. 59: 7100-3. PMID 26303798 DOI: 10.1128/Aac.01512-15  0.445
2015 Lasserre C, De Saint Martin L, Cuzon G, Bogaerts P, Lamar E, Glupczynski Y, Naas T, Tandé D. Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes. Journal of Clinical Microbiology. 53: 2163-71. PMID 25926485 DOI: 10.1128/Jcm.03467-14  0.304
2015 Dortet L, Oueslati S, Jeannot K, Tandé D, Naas T, Nordmann P. Genetic and biochemical characterization of OXA-405, an OXA-48-type extended-spectrum β-lactamase without significant carbapenemase activity. Antimicrobial Agents and Chemotherapy. 59: 3823-8. PMID 25870062 DOI: 10.1128/Aac.05058-14  0.513
2015 Nijhuis RH, Oueslati S, Zhou K, Bosboom RW, Rossen JW, Naas T. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity. The Journal of Antimicrobial Chemotherapy. 70: 1429-33. PMID 25630648 DOI: 10.1093/Jac/Dkv002  0.458
2013 Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Probe ligation and real-time detection of KPC, OXA-48, VIM, IMP, and NDM carbapenemase genes. Diagnostic Microbiology and Infectious Disease. 76: 502-5. PMID 23791387 DOI: 10.1016/J.Diagmicrobio.2013.05.004  0.364
2013 Cuzon G, Naas T, Correa A, Quinn JP, Villegas MV, Nordmann P. Dissemination of the KPC-2 carbapenemase in non-Klebsiella pneumoniae enterobacterial isolates from Colombia. International Journal of Antimicrobial Agents. 42: 59-62. PMID 23664581 DOI: 10.1016/J.Ijantimicag.2013.04.002  0.446
2013 Naas T, Bonnin RA, Cuzon G, Villegas MV, Nordmann P. Complete sequence of two KPC-harbouring plasmids from Pseudomonas aeruginosa Journal of Antimicrobial Chemotherapy. 68: 1757-1762. PMID 23569197 DOI: 10.1093/Jac/Dkt094  0.425
2013 Naas T, Cotellon G, Ergani A, Nordmann P. Real-time PCR for detection of blaOXA-48 genes from stools. The Journal of Antimicrobial Chemotherapy. 68: 101-4. PMID 22969079 DOI: 10.1093/Jac/Dks340  0.359
2012 Aubert D, Naas T, Nordmann P. Integrase-mediated recombination of the veb1 gene cassette encoding an extended-spectrum β-lactamase. Plos One. 7: e51602. PMID 23251590 DOI: 10.1371/Journal.Pone.0051602  0.417
2012 Bonnin RA, Poirel L, Naas T, Pirs M, Seme K, Schrenzel J, Nordmann P. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe Clinical Microbiology and Infection. 18. PMID 22738206 DOI: 10.1111/J.1469-0691.2012.03928.X  0.478
2012 Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM). The Journal of Antimicrobial Chemotherapy. 67: 1865-9. PMID 22604450 DOI: 10.1093/Jac/Dks156  0.443
2012 Boulanger A, Naas T, Fortineau N, Figueiredo S, Nordmann P. NDM-1-producing Acinetobacter baumannii from Algeria. Antimicrobial Agents and Chemotherapy. 56: 2214-5. PMID 22290985 DOI: 10.1128/Aac.05653-11  0.372
2012 Bonnin RA, Naas T, Poirel L, Nordmann P. Phenotypic, biochemical, and molecular techniques for detection of metallo-β-lactamase NDM in Acinetobacter baumannii Journal of Clinical Microbiology. 50: 1419-1421. PMID 22259204 DOI: 10.1128/Jcm.06276-11  0.36
2012 Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerging Infectious Diseases. 17: 1791-8. PMID 22000347 DOI: 10.3201/eid1710.110655  0.304
2012 Poirel L, Ronco E, Naas T, Nordmann P. Extended-spectrum β-lactamase TEM-4 in Pseudomonas aeruginosa. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 5: 651-2. PMID 11851699 DOI: 10.1111/J.1469-0691.1999.Tb00425.X  0.44
2012 Cantón R, Akóva M, Carmeli Y, Giske C, Glupczynski Y, Gniadkowski M, Livermore D, Miriagou V, Naas T, Rossolini G, Samuelsen Ø, Seifert H, Woodford N, Nordmann P. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe Clinical Microbiology and Infection. 18: 413-431. DOI: 10.1111/J.1469-0691.2012.03821.X  0.399
2011 Naas T, Cattoen C, Bernusset S, Cuzon G, Nordmann P. First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France. Antimicrobial Agents and Chemotherapy. 56: 1664-5. PMID 22203599 DOI: 10.1128/Aac.06328-11  0.481
2011 Cuzon G, Naas T, Villegas MV, Correa A, Quinn JP, Nordmann P. Wide dissemination of Pseudomonas aeruginosa producing beta-lactamase blaKPC-2 gene in Colombia. Antimicrobial Agents and Chemotherapy. 55: 5350-3. PMID 21844315 DOI: 10.1128/Aac.00297-11  0.451
2011 Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France. Antimicrobial Agents and Chemotherapy. 55: 4933-4. PMID 21768511 DOI: 10.1128/Aac.00719-11  0.51
2011 Bogaerts P, Hujer AM, Naas T, de Castro RR, Endimiani A, Nordmann P, Glupczynski Y, Bonomo RA. Multicenter evaluation of a new DNA microarray for rapid detection of clinically relevant bla genes from beta-lactam-resistant gram-negative bacteria. Antimicrobial Agents and Chemotherapy. 55: 4457-60. PMID 21746960 DOI: 10.1128/Aac.00353-11  0.433
2011 Naas T, Bogaerts P, Kostyanev T, Cuzon G, Huang TD, Ozsu S, Nordmann P, Glupczynski Y. Silent spread of IMP-13-producing Pseudomonas aeruginosa belonging to sequence type 621 in Belgium. The Journal of Antimicrobial Chemotherapy. 66: 2178-9. PMID 21693463 DOI: 10.1093/Jac/Dkr252  0.446
2011 Naas T, Ergani A, Carrër A, Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrobial Agents and Chemotherapy. 55: 4038-43. PMID 21690281 DOI: 10.1128/Aac.01734-10  0.379
2011 Naas T, Bentchouala C, Cuzon G, Yaou S, Lezzar A, Smati F, Nordmann P. Outbreak of Salmonella enterica serotype Infantis producing ArmA 16S RNA methylase and CTX-M-15 extended-spectrum β-lactamase in a neonatology ward in Constantine, Algeria. International Journal of Antimicrobial Agents. 38: 135-9. PMID 21658916 DOI: 10.1016/J.Ijantimicag.2011.04.012  0.454
2011 Djamdjian L, Naas T, Tandé D, Cuzon G, Hanrotel-Saliou C, Nordmann P. CTX-M-93, a CTX-M Variant Lacking Penicillin Hydrolytic Activity Antimicrobial Agents and Chemotherapy. 55: 1861-1866. PMID 21343457 DOI: 10.1128/Aac.01656-10  0.354
2011 Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrobial Agents and Chemotherapy. 55: 2420-3. PMID 21343451 DOI: 10.1128/Aac.01452-10  0.429
2011 Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P. Evaluation of a DNA microarray (Check-MDR CT102) for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 carbapenemases. Journal of Clinical Microbiology. 49: 1608-13. PMID 21325547 DOI: 10.1128/Jcm.02607-10  0.444
2011 Nordmann P, Naas T, Poirel L. Global Spread of Carbapenemase-producingEnterobacteriaceae Emerging Infectious Diseases. 17: 1791-1798. DOI: 10.3201/Eid1710.110655  0.413
2011 Boisrame-Gastrin S, Tande D, Munck M, Gouriou S, Nordmann P, Naas T. Salmonella carriage in adopted children from Mali: 2001-08 Journal of Antimicrobial Chemotherapy. 66: 2271-2276. DOI: 10.1093/Jac/Dkr307  0.43
2010 Bogaerts P, Naas T, El Garch F, Cuzon G, Deplano A, Delaire T, Huang TD, Lissoir B, Nordmann P, Glupczynski Y. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrobial Agents and Chemotherapy. 54: 4872-8. PMID 20805394 DOI: 10.1128/Aac.00871-10  0.496
2010 Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, Gales AC, Venezia SN, Quinn JP, Nordmann P. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerging Infectious Diseases. 16: 1349-56. PMID 20735917 DOI: 10.3201/eid1609.091389  0.336
2010 Naas T, Cuzon G, Truong H, Bernabeu S, Nordmann P. Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum beta-lactamases and KPC carbapenemases. Antimicrobial Agents and Chemotherapy. 54: 3086-92. PMID 20547813 DOI: 10.1128/Aac.01298-09  0.42
2010 Naas T, Cuzon G, Babics A, Fortineau N, Boytchev I, Gayral F, Nordmann P. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase. The Journal of Antimicrobial Chemotherapy. 65: 1305-6. PMID 20382724 DOI: 10.1093/Jac/Dkq117  0.323
2010 Cuzon G, Naas T, Guibert M, Nordmann P. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. International Journal of Antimicrobial Agents. 35: 265-8. PMID 20034767 DOI: 10.1016/j.ijantimicag.2009.10.021  0.378
2010 Cuzon G, Naas T, Truong H, Villegas M, Wisell KT, Carmeli Y, Gales AC, Navon-Venezia S, Quinn JP, Nordmann P. Worldwide Diversity ofKlebsiella pneumoniaeThat Produce β-LactamaseblaKPC-2Gene1 Emerging Infectious Diseases. 16: 1349-1356. DOI: 10.3201/Eid1609.091389  0.468
2010 Tande D, Boisrame-Gastrin S, Munck MR, Hery-Arnaud G, Gouriou S, Jallot N, Nordmann P, Naas T. Intrafamilial transmission of extended-spectrum- -lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children Journal of Antimicrobial Chemotherapy. 65: 859-865. DOI: 10.1093/Jac/Dkq068  0.386
2010 Cuzon G, Naas T, Nordmann P. Carbapénèmases de type KPC : quel enjeu en microbiologie clinique ? Pathologie Biologie. 58: 39-45. DOI: 10.1016/J.Patbio.2009.07.026  0.459
2010 Cuzon G, Naas T, Lesenne A, Benhamou M, Nordmann P. Plasmid-mediated carbapenem-hydrolysing OXA-48 β-lactamase in Klebsiella pneumoniae from Tunisia International Journal of Antimicrobial Agents. 36: 91-93. DOI: 10.1016/J.Ijantimicag.2010.02.014  0.459
2010 Cuzon G, Naas T, Guibert M, Nordmann P. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum β-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase International Journal of Antimicrobial Agents. 35: 265-268. DOI: 10.1016/J.Ijantimicag.2009.10.021  0.532
2009 Girlich D, Kolb A, Naas T, Nordmann P. Characterization of regulatory element Rp3 of regulation of beta-lactamases from Ralstonia pickettii. Fems Microbiology Letters. 301: 50-6. PMID 19817868 DOI: 10.1111/J.1574-6968.2009.01796.X  0.367
2009 Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D beta-lactamases. Antimicrobial Agents and Chemotherapy. 54: 24-38. PMID 19721065 DOI: 10.1128/Aac.01512-08  0.412
2009 Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. The Lancet. Infectious Diseases. 9: 228-36. PMID 19324295 DOI: 10.1016/S1473-3099(09)70054-4  0.437
2009 Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide Dissemination of theblaOXA-23Carbapenemase Gene ofAcinetobacter baumannii1 Emerging Infectious Diseases. 16: 35-40. DOI: 10.3201/Eid1601.090852  0.397
2009 Ozen N, Ergani A, Naas T, Ögünç D, Gültekin M, Colak D, Nordmann P. Outbreak of Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Turkey The Open Antimicrobial Agents Journal. 1: 1-8. DOI: 10.2174/1876518100901010001  0.431
2009 Naas T, Bentchouala C, Lima S, Lezzar A, Smati F, Scheftel J, Nordmann P. Plasmid-mediated 16S rRNA methylases among extended-spectrum- -lactamase-producing Salmonella enterica Senftenberg isolates from Algeria Journal of Antimicrobial Chemotherapy. 64: 866-868. DOI: 10.1093/Jac/Dkp312  0.412
2008 Le Hello S, Falcot V, Lacassin F, Baumann F, Nordmann P, Naas T. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 14: 977-81. PMID 18828857 DOI: 10.1111/J.1469-0691.2008.02068.X  0.423
2008 Bogaerts P, Cuzon G, Naas T, Bauraing C, Deplano A, Lissoir B, Nordmann P, Glupczynski Y. Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrobial Agents and Chemotherapy. 52: 4205-6. PMID 18765689 DOI: 10.1128/AAC.01121-08  0.313
2008 Naas T, Namdari F, Bogaerts P, Huang TD, Glupczynski Y, Nordmann P. Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase. Antimicrobial Agents and Chemotherapy. 52: 3898-904. PMID 18663027 DOI: 10.1128/Aac.00403-08  0.403
2008 Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Huang TD, Nordmann P. Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrobial Agents and Chemotherapy. 52: 3463-4. PMID 18644970 DOI: 10.1128/Aac.00543-08  0.397
2008 Ergani-Ozcan A, Naas T, Baysan BO, Ogunc D, Inan D, Colak D, Nordmann P. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital. The Journal of Antimicrobial Chemotherapy. 61: 1033-9. PMID 18319236 DOI: 10.1093/Jac/Dkn066  0.371
2008 Réglier-Poupet H, Naas T, Carrer A, Cady A, Adam J, Fortineau N, Poyart C, Nordmann P. Performance of chromID ESBL, a chromogenic medium for detection of Enterobacteriaceae producing extended-spectrum β-lactamases Journal of Medical Microbiology. 57: 310-315. PMID 18287293 DOI: 10.1099/Jmm.0.47625-0  0.399
2008 Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrobial Agents and Chemotherapy. 52: 1257-63. PMID 18227185 DOI: 10.1128/AAC.01451-07  0.315
2008 Poirel L, Naas T, Nordmann P. Genetic support of extended-spectrum beta-lactamases. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 75-81. PMID 18154530 DOI: 10.1111/J.1469-0691.2007.01865.X  0.414
2008 Naas T, Poirel L, Nordmann P. Minor extended-spectrum beta-lactamases. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 42-52. PMID 18154527 DOI: 10.1111/J.1469-0691.2007.01861.X  0.424
2008 Cuzon G, Naas T, Fortineau N, Nordmann P. Novel Chromogenic Medium for Detection of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis Journal of Clinical Microbiology. 46: 2442-2444. DOI: 10.1128/Jcm.00492-08  0.415
2008 Naas T, Cuzon G, Villegas M, Lartigue M, Quinn JP, Nordmann P. Genetic Structures at the Origin of Acquisition of the β-Lactamase blaKPC Gene Antimicrobial Agents and Chemotherapy. 52: 1257-1263. DOI: 10.1128/Aac.01451-07  0.462
2008 Bogaerts P, Cuzon G, Bauraing C, Deplano A, Lissoir B, Nordmann P, Glupczynski Y, Naas T. Carbapenem-Resistant Acinetobacter baumannii Isolates Expressing the blaOXA-23 Gene Associated with ISAba4 in Belgium Antimicrobial Agents and Chemotherapy. 52: 4205-4206. DOI: 10.1128/Aac.01121-08  0.492
2007 Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrobial Agents and Chemotherapy. 52: 796-7. PMID 18056283 DOI: 10.1128/Aac.01180-07  0.535
2007 Girlich D, Leclercq R, Naas T, Nordmann P. Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii. Antimicrobial Agents and Chemotherapy. 51: 4009-14. PMID 17846134 DOI: 10.1128/Aac.00537-07  0.4
2007 Nordmann P, Naas T, Fortineau N, Poirel L. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Current Opinion in Microbiology. 10: 436-40. PMID 17765004 DOI: 10.1016/J.Mib.2007.07.004  0.408
2007 Naas T, Kernbaum S, Allali S, Nordmann P. Multidrug-resistant Acinetobacter baumannii, Russia. Emerging Infectious Diseases. 13: 669-71. PMID 17561578 DOI: 10.3201/Eid1304.060755  0.506
2007 Naas T, Aubert D, Ozcan A, Nordmann P. Chromosome-encoded narrow-spectrum Ambler class A beta-lactamase GIL-1 from Citrobacter gillenii. Antimicrobial Agents and Chemotherapy. 51: 1365-72. PMID 17242148 DOI: 10.1128/Aac.01152-06  0.407
2007 Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. Genetics and Expression of the Carbapenem-Hydrolyzing Oxacillinase Gene blaOXA-23 in Acinetobacter baumannii Antimicrobial Agents and Chemotherapy. 51: 1530-1533. DOI: 10.1128/Aac.01132-06  0.427
2007 Poirel L, Wenger A, Bernabeu S, Bille J, Naas T, Nordmann P. SME-2-Producing Serratia marcescens Isolate from Switzerland Antimicrobial Agents and Chemotherapy. 51: 2282-2283. DOI: 10.1128/Aac.00309-07  0.477
2007 Bogaerts P, Naas T, Bauraing C, Deplano A, Piérard D, Nordmann P, Glupczynski Y. P1006 Imported cases of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in Belgium: characterisation and unusual loss of resistance International Journal of Antimicrobial Agents. 29: S268. DOI: 10.1016/S0924-8579(07)70847-6  0.396
2007 Ozcan A, Baysan BO, Ogunc D, Inan D, Naas T, Colak D, Nordmann P. P686 Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a Turkish University Hospital International Journal of Antimicrobial Agents. 29. DOI: 10.1016/S0924-8579(07)70527-7  0.344
2007 Oxacelay C, Özcan A, Naas T, Nordmann P. P572 Identification of CTX-M-type extended-spectrum β-lactamases in urine based on real-time PCR International Journal of Antimicrobial Agents. 29: S130-S131. DOI: 10.1016/S0924-8579(07)70415-6  0.364
2007 Cuzon G, Naas T, Fortineau N, Nordmann P. O104 A novel chromogenic medium for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis detection International Journal of Antimicrobial Agents. 29: S22. DOI: 10.1016/S0924-8579(07)70073-0  0.356
2007 Naas T, Nordmann P, Heidt A. Intercountry transfer of PER-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii from Romania International Journal of Antimicrobial Agents. 29: 226-228. DOI: 10.1016/J.Ijantimicag.2006.08.032  0.418
2006 Naas T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, Bernet C, Verdeil X, Astagneau P, Desenclos JC, Nordmann P. VEB-1 Extended-spectrum beta-lactamase-producing Acinetobacter baumannii, France. Emerging Infectious Diseases. 12: 1214-22. PMID 16965700 DOI: 10.3201/Eid1708.051547  0.37
2006 Bogaerts P, Naas T, Wybo I, Bauraing C, Soetens O, Piérard D, Nordmann P, Glupczynski Y. Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium. Journal of Clinical Microbiology. 44: 4189-92. PMID 16957031 DOI: 10.1128/JCM.00796-06  0.37
2006 Aubert D, Naas T, Héritier C, Poirel L, Nordmann P. Functional Characterization of IS1999, an IS4 Family Element Involved in Mobilization and Expression of β-Lactam Resistance Genes Journal of Bacteriology. 188: 6506-6514. PMID 16952941 DOI: 10.1128/Jb.00375-06  0.425
2006 Girlich D, Naas T, Nordmann P. Regulation of class D beta-lactamase gene expression in Ralstonia pickettii. Microbiology (Reading, England). 152: 2661-2672. PMID 16946261 DOI: 10.1099/Mic.0.29027-0  0.38
2006 Poirel L, Naas T, Nordmann P. Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases. Journal of Clinical Microbiology. 44: 3008-11. PMID 16891529 DOI: 10.1128/Jcm.02576-05  0.376
2006 Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. The Journal of Antimicrobial Chemotherapy. 58: 178-82. PMID 16670107 DOI: 10.1093/Jac/Dkl178  0.344
2006 Naas T, Aubert D, Lambert T, Nordmann P. Complex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene. Antimicrobial Agents and Chemotherapy. 50: 1745-52. PMID 16641445 DOI: 10.1128/Aac.50.5.1745-1752.2006  0.431
2006 Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrobial Agents and Chemotherapy. 49: 4423-4. PMID 16189140 DOI: 10.1128/Aac.49.10.4423-4424.2005  0.535
2006 Bogaerts P, Naas T, Wybo I, Bauraing C, Soetens O, Pierard D, Nordmann P, Glupczynski Y. Outbreak of Infection by Carbapenem-Resistant Acinetobacter baumannii Producing the Carbapenemase OXA-58 in Belgium Journal of Clinical Microbiology. 44: 4189-4192. DOI: 10.1128/Jcm.00796-06  0.491
2006 Naas T, Oxacelay C, Nordmann P. Identification of CTX-M-Type Extended-Spectrum-β-Lactamase Genes Using Real-Time PCR and Pyrosequencing Antimicrobial Agents and Chemotherapy. 51: 223-230. DOI: 10.1128/Aac.00611-06  0.37
2006 Naas T, Poirel L, Nordmann P. Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type β-lactamases in Acinetobacter baumannii Clinical Microbiology and Infection. 12: 1236-1240. DOI: 10.1111/J.1469-0691.2006.01563.X  0.54
2005 Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P. Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. Journal of Clinical Microbiology. 43: 4885-8. PMID 16145167 DOI: 10.1128/Jcm.43.9.4885-4888.2005  0.424
2005 Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. Journal of Clinical Microbiology. 43: 4826-9. PMID 16145150 DOI: 10.1128/Jcm.43.9.4826-4829.2005  0.463
2005 Naas T, Fortineau N, Snanoudj R, Spicq C, Durrbach A, Nordmann P. First nosocomial outbreak of vancomycin-resistant Enterococcus faecium expressing a VanD-like phenotype associated with a vanA genotype. Journal of Clinical Microbiology. 43: 3642-9. PMID 16081891 DOI: 10.1128/Jcm.43.8.3642-3649.2005  0.464
2005 Aubert D, Naas T, Lartigue MF, Nordmann P. Novel genetic structure associated with an extended-spectrum beta-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrobial Agents and Chemotherapy. 49: 3590-2. PMID 16048993 DOI: 10.1128/AAC.49.8.3590-3592.2005  0.328
2005 Naas T, Lezzar A, Bentchouala C, Smati F, Scheftel JM, Monteil H, Nordmann P. Multidrug-resistant Salmonella enterica serotype Senftenberg isolates producing CTX-M beta-lactamases from Constantine, Algeria. The Journal of Antimicrobial Chemotherapy. 56: 439-40. PMID 15967765 DOI: 10.1093/Jac/Dki216  0.432
2005 Carbonne A, Naas T, Blanckaert K, Couzigou C, Cattoen C, Chagnon JL, Nordmann P, Astagneau P. Investigation of a nosocomial outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. The Journal of Hospital Infection. 60: 14-8. PMID 15823651 DOI: 10.1016/J.Jhin.2004.07.027  0.39
2005 Nordmann P, Naas T. Transmission of methicillin-resistant Staphylococcus aureus to a microbiologist. The New England Journal of Medicine. 352: 1489-90. PMID 15814888 DOI: 10.1056/Nejm200504073521418  0.35
2005 Aubert D, Naas T, Lartigue M, Nordmann P. Novel Genetic Structure Associated with an Extended-Spectrum β-Lactamase blaVEB Gene in a Providencia stuartii Clinical Isolate from Algeria Antimicrobial Agents and Chemotherapy. 49: 3590-3592. DOI: 10.1128/Aac.49.8.3590-3592.2005  0.461
2005 Naas T, Fortineau N, Spicq C, Robert J, Jarlier V, Nordmann P. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital Journal of Hospital Infection. 61: 321-329. DOI: 10.1016/J.Jhin.2005.01.027  0.394
2004 Naas T, Aubert D, Vimont S, Nordmann P. Identification of a chromosome-borne class C beta-lactamase from Erwinia rhapontici. The Journal of Antimicrobial Chemotherapy. 54: 932-5. PMID 15472000 DOI: 10.1093/Jac/Dkh446  0.337
2004 Mammeri H, Nazic H, Naas T, Poirel L, Léotard S, Nordmann P. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy. 48: 4050-3. PMID 15388478 DOI: 10.1128/Aac.48.10.4050-4053.2004  0.488
2004 Aubert D, Girlich D, Naas T, Nagarajan S, Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum beta-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrobial Agents and Chemotherapy. 48: 3284-90. PMID 15328086 DOI: 10.1128/Aac.48.9.3284-3290.2004  0.409
2004 Girlich D, Naas T, Nordmann P. Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. 48: 2043-2048. DOI: 10.1128/Aac.48.6.2043-2048.2004  0.416
2004 Girlich D, Naas T, Nordmann P. OXA-60, a Chromosomal, Inducible, and Imipenem-Hydrolyzing Class D β-Lactamase from Ralstonia pickettii Antimicrobial Agents and Chemotherapy. 48: 4217-4225. DOI: 10.1128/Aac.48.11.4217-4225.2004  0.469
2003 Aubert D, Naas T, Nordmann P. IS1999 increases expression of the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa. Journal of Bacteriology. 185: 5314-9. PMID 12923109 DOI: 10.1128/Jb.185.17.5314-5319.2003  0.392
2003 Naas T, Bellais S, Nordmann P. Molecular and biochemical characterization of a carbapenem-hydrolysing beta-lactamase from Flavobacterium johnsoniae. The Journal of Antimicrobial Chemotherapy. 51: 267-73. PMID 12562690 DOI: 10.1093/jac/dkg069  0.307
2003 Naas T, Zerbib M, Girlich D, Nordmann P. Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome. Antimicrobial Agents and Chemotherapy. 47: 19-26. PMID 12499163 DOI: 10.1128/AAC.47.1.19-26.2003  0.345
2003 Vimont S, Poirel L, Naas T, Nordmann P. Identification of a chromosome-borne expanded-spectrum class a beta-lactamase from Erwinia persicina. Antimicrobial Agents and Chemotherapy. 46: 3401-5. PMID 12384342 DOI: 10.1128/Aac.46.11.3401-3405.2002  0.423
2003 Naas T, Zerbib M, Girlich D, Nordmann P. Integration of a Transposon Tn1-Encoded Inhibitor-Resistant β-Lactamase Gene, blaTEM-67 from Proteus mirabilis, into the Escherichia coli Chromosome Antimicrobial Agents and Chemotherapy. 47: 19-26. DOI: 10.1128/Aac.47.1.19-26.2003  0.486
2003 Naas T. Molecular and biochemical characterization of a carbapenem-hydrolysing beta-lactamase from Flavobacterium johnsoniae Journal of Antimicrobial Chemotherapy. 51: 267-273. DOI: 10.1093/Jac/Dkg069  0.42
2002 Naas T, Aubert D, Fortineau N, Nordmann P. Cloning and sequencing of the beta-lactamase gene and surrounding DNA sequences of Citrobacter braakii, Citrobacter murliniae, Citrobacter werkmanii, Escherichia fergusonii and Enterobacter cancerogenus. Fems Microbiology Letters. 215: 81-7. PMID 12393205 DOI: 10.1111/J.1574-6968.2002.Tb11374.X  0.421
2002 Colak D, Naas T, Gunseren F, Fortineau N, Ogunc D, Gultekin M, Nordmann P. First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. The Journal of Antimicrobial Chemotherapy. 50: 397-401. PMID 12205065 DOI: 10.1093/Jac/Dkf134  0.386
2002 Bellais S, Naas T, Nordmann P. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum. Antimicrobial Agents and Chemotherapy. 46: 966-70. PMID 11897576 DOI: 10.1128/Aac.46.4.966-970.2002  0.444
2002 Girlich D, Naas T, Leelaporn A, Poirel L, Fennewald M, Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-pectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 34: 603-11. PMID 11807680 DOI: 10.1086/338786  0.479
2002 Sougakoff W, L'Hermite G, Pernot L, Naas T, Guillet V, Nordmann P, Jarlier V, Delettré J. Structure of the imipenem-hydrolyzing class A β-­lactamase SME-1 from Serratia marcescens Acta Crystallographica Section D-Biological Crystallography. 58: 267-274. PMID 11807251 DOI: 10.1107/S0907444901019606  0.444
2002 Poirel L, Gerome P, De Champs C, Stephanazzi J, Naas T, Nordmann P. Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 46: 566-9. PMID 11796380 DOI: 10.1128/AAC.46.2.566-569.2002  0.378
2002 Poirel L, Naas T, Le Thomas I, Karim A, Bingen E, Nordmann P. CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrobial Agents and Chemotherapy. 45: 3355-61. PMID 11709308 DOI: 10.1128/Aac.45.12.3355-3361.2001  0.369
2002 Bellais S, Naas T, Nordmann P. Genetic and Biochemical Characterization of CGB-1, an Ambler Class B Carbapenem-Hydrolyzing β-Lactamase from Chryseobacterium gleum Antimicrobial Agents and Chemotherapy. 46: 2791-2796. DOI: 10.1128/Aac.46.9.2791-2796.2002  0.476
2002 Poirel L, Gerome P, De Champs C, Stephanazzi J, Naas T, Nordmann P. Integron-Located oxa-32 Gene Cassette Encoding an Extended-Spectrum Variant of OXA-2 β-Lactamase from Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. 46: 566-569. DOI: 10.1128/Aac.46.2.566-569.2002  0.526
2001 Naas T, Benaoudia F, Lebrun L, Nordmann P. Molecular identification of TEM-1 beta-lactamase in a Pasteurella multocida isolate of human origin. European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology. 20: 210-3. PMID 11347675 DOI: 10.1007/PL00011254  0.308
2001 Fortineau N, Naas T, Gaillot O, Nordmann P. SHV-type extended-spectrum beta-lactamase in a Shigella flexneri clinical isolate. The Journal of Antimicrobial Chemotherapy. 47: 685-8. PMID 11328785 DOI: 10.1093/Jac/47.5.685  0.421
2001 Poirel L, Laurent F, Naas T, Labia R, Boiron P, Nordmann P. Molecular and biochemical analysis of AST-1, a class A beta-lactamase from Nocardia asteroides sensu stricto. Antimicrobial Agents and Chemotherapy. 45: 878-82. PMID 11181374 DOI: 10.1128/Aac.45.3.878-882.2001  0.414
2001 Poirel L, Girlich D, Naas T, Nordmann P. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene. Antimicrobial Agents and Chemotherapy. 45: 447-53. PMID 11158739 DOI: 10.1128/Aac.45.2.447-453.2001  0.48
2001 Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P. Heterogeneity of AmpC cephalosporinases of Hafnia alvei clinical isolates expressing inducible or constitutive ceftazidime resistance phenotypes. Antimicrobial Agents and Chemotherapy. 44: 3220-3. PMID 11036059 DOI: 10.1128/Aac.44.11.3220-3223.2000  0.387
2001 Naas T, Mikami Y, Imai T, Poirel L, Nordmann P. Characterization of In53, a Class 1 Plasmid- and Composite Transposon-Located Integron of Escherichia coli Which Carries an Unusual Array of Gene Cassettes Journal of Bacteriology. 183: 235-249. DOI: 10.1128/Jb.183.1.235-249.2001  0.446
2001 Poirel L, Weldhagen GF, Naas T, De Champs C, Dove MG, Nordmann P. GES-2, a Class A β-Lactamase fromPseudomonas aeruginosa with Increased Hydrolysis of Imipenem Antimicrobial Agents and Chemotherapy. 45: 2598-2603. DOI: 10.1128/Aac.45.9.2598-2603.2001  0.501
2001 Naas T, Massuard S, Garnier F, Nordmann P. AmpD Is Required for Regulation of Expression of NmcA, a Carbapenem-Hydrolyzing β-Lactamase ofEnterobacter cloacae Antimicrobial Agents and Chemotherapy. 45: 2908-2915. DOI: 10.1128/Aac.45.10.2908-2915.2001  0.455
2000 Bellais S, Poirel L, Leotard S, Naas T, Nordmann P. Genetic Diversity of Carbapenem-Hydrolyzing Metallo-β-Lactamases from Chryseobacterium(Flavobacterium) indologenes Antimicrobial Agents and Chemotherapy. 44: 3028-3034. PMID 11036018 DOI: 10.1128/Aac.44.11.3028-3034.2000  0.496
2000 Bellais S, Aubert D, Naas T, Nordmann P. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum. Antimicrobial Agents and Chemotherapy. 44: 1878-86. PMID 10858348 DOI: 10.1128/Aac.44.7.1878-1886.2000  0.468
2000 Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrobial Agents and Chemotherapy. 44: 891-7. PMID 10722487 DOI: 10.1128/Aac.44.4.891-897.2000  0.444
2000 Nordmann P, Poirel L, Kubina M, Casetta A, Naas T. Biochemical-Genetic Characterization and Distribution of OXA-22, a Chromosomal and Inducible Class D β-Lactamase fromRalstonia (Pseudomonas)pickettii Antimicrobial Agents and Chemotherapy. 44: 2201-2204. DOI: 10.1128/Aac.44.8.2201-2204.2000  0.463
2000 Girlich D, Naas T, Bellais S, Poirel L, Karim A, Nordmann P. Biochemical-Genetic Characterization and Regulation of Expression of an ACC-1-Like Chromosome-Borne Cephalosporinase fromHafnia alvei Antimicrobial Agents and Chemotherapy. 44: 1470-1478. DOI: 10.1128/Aac.44.6.1470-1478.2000  0.45
2000 Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum β-Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy. 44: 622-632. DOI: 10.1128/Aac.44.3.622-632.2000  0.519
2000 Bellais S, Poirel L, Naas T, Girlich D, Nordmann P. Genetic-Biochemical Analysis and Distribution of the Ambler Class A β-Lactamase CME-2, Responsible for Extended-Spectrum Cephalosporin Resistance inChryseobacterium (Flavobacterium)meningosepticum Antimicrobial Agents and Chemotherapy. 44: 1-9. DOI: 10.1128/Aac.44.1.1-9.2000  0.491
2000 Naas T. Integron-located VEB-1 extended-spectrum beta-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam Journal of Antimicrobial Chemotherapy. 46: 703-711. DOI: 10.1093/Jac/46.5.703  0.447
1999 Casadesús J, Naas T, Garzón A, Arini A, Torreblanca J, Arber W. Lack of hotspot targets: a constraint for IS30 transposition in Salmonella. Gene. 238: 231-9. PMID 10570999 DOI: 10.1016/S0378-1119(99)00256-5  0.312
1999 Sougakoff W, Naas T, Nordmann P, Collatz E, Jarlier V. Role of ser-237 in the substrate specificity of the carbapenem-hydrolyzing class A beta-lactamase Sme-1. Biochimica Et Biophysica Acta. 1433: 153-8. PMID 10446368 DOI: 10.1016/S0167-4838(99)00138-7  0.358
1999 Naas T, Poirel L, Karim A, Nordmann P. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum beta-lactamase VEB-1 in Pseudomonas aeruginosa. Fems Microbiology Letters. 176: 411-9. PMID 10427724 DOI: 10.1111/J.1574-6968.1999.Tb13691.X  0.452
1999 Laurent F, Poirel L, Naas T, Chaibi EB, Labia R, Boiron P, Nordmann P. Biochemical-Genetic Analysis and Distribution of FAR-1, a Class A β-Lactamase from Nocardia farcinica Antimicrobial Agents and Chemotherapy. 43: 1644-1650. PMID 10390216 DOI: 10.1128/Aac.43.7.1644  0.471
1999 Poirel L, Guibert M, Girlich D, Naas T, Nordmann P. Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates. Antimicrobial Agents and Chemotherapy. 43: 769-76. PMID 10103179 DOI: 10.1128/Aac.43.4.769  0.406
1999 Bellais S, Léotard S, Poirel L, Naas T, Nordmann P. Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes. Fems Microbiology Letters. 171: 127-32. PMID 10077836 DOI: 10.1111/J.1574-6968.1999.Tb13422.X  0.399
1999 Poirel L, Naas T, Guibert M, Chaibi EB, Labia R, Nordmann P. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrobial Agents and Chemotherapy. 43: 573-81. PMID 10049269 DOI: 10.1128/Aac.43.3.573  0.486
1999 Naas T, Philippon L, Poirel L, Ronco E, Nordmann P. An SHV-Derived Extended-Spectrum β-Lactamase in Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. 43: 1281-1284. DOI: 10.1128/Aac.43.5.1281  0.376
1999 Poirel L, Guibert M, Bellais S, Naas T, Nordmann P. Integron- and Carbenicillinase-Mediated Reduced Susceptibility to Amoxicillin-Clavulanic Acid in Isolates of Multidrug-ResistantSalmonella enterica Serotype Typhimurium DT104 from French Patients Antimicrobial Agents and Chemotherapy. 43: 1098-1104. DOI: 10.1128/Aac.43.5.1098  0.478
1999 Naas T, Poirel L, Nordmann P. Molecular characterisation of In51, a class 1 integron containing a novel aminoglycoside adenylyltransferase gene cassette, aadA6, in Pseudomonas aeruginosa Biochimica Et Biophysica Acta (Bba) - Gene Structure and Expression. 1489: 445-451. DOI: 10.1016/S0167-4781(99)00202-X  0.445
1998 Naas T, Sougakoff W, Casetta A, Nordmann P. Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 42: 2074-83. PMID 9687410 DOI: 10.1128/Aac.42.8.2074  0.441
1998 BOUTHORS A, DAGONEAU-BLANCHARD N, NAAS T, NORDMANN P, JARLIER V, SOUGAKOFF W. Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 β-lactamase hydrolysing third-generation cephalosporins Biochemical Journal. 330: 1443-1449. DOI: 10.1042/Bj3301443  0.416
1998 Cosseron-Zerbib M, Afonso A, Naas T, Durand P, Meyer L, Costa Y, El Helali N, Huault G, Nordmann P. A control programme for MRSA (methicillin-resistant Staphylococcus aureus) containment in a paediatric intensive care unit: evaluation and impact on infections caused by other micro-organisms Journal of Hospital Infection. 40: 225-235. DOI: 10.1016/S0195-6701(98)90140-2  0.31
1997 Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 41: 2188-95. PMID 9333046 DOI: 10.1128/Aac.41.10.2188  0.476
1997 Nordmann P, Naas T. The increasing problem of resistance to cephalosporins Current Opinion in Infectious Diseases. 10: 435-439. DOI: 10.1097/00001432-199712000-00004  0.342
1996 Sougakoff W, Jarlier V, Delettré J, Colloc'h N, L'Hermite G, Nordmann P, Naas T. Purification, crystallization, and preliminary X-Ray diffraction analysis of the carbapenem-hydrolyzing class A beta-lactamase Sme-1 from Serratia marcescens. Journal of Structural Biology. 116: 313-6. PMID 8812987 DOI: 10.1006/Jsbi.1996.0046  0.312
1995 Naas T, Blot M, Fitch WM, Arber W. Dynamics of IS-related genetic rearrangements in resting Escherichia coli K-12. Molecular Biology and Evolution. 12: 198-207. PMID 7700149 DOI: 10.1093/Oxfordjournals.Molbev.A040198  0.325
1995 Naas T, Livermore DM, Nordmann P. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta- lactamase regulators Antimicrobial Agents and Chemotherapy. 39: 629-637. DOI: 10.1128/Aac.39.3.629  0.357
1994 Nordmann P, Naas T. Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrobial Agents and Chemotherapy. 38: 104-14. PMID 8141562 DOI: 10.1128/Aac.38.1.104  0.404
1994 Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6. Antimicrobial Agents and Chemotherapy. 38: 1262-70. PMID 8092824 DOI: 10.1128/Aac.38.6.1262  0.414
1994 Naas T, Nordmann P. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proceedings of the National Academy of Sciences. 91: 7693-7697. DOI: 10.1073/Pnas.91.16.7693  0.422
1993 Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 37: 962-969. DOI: 10.1128/Aac.37.5.962  0.452
1993 Nordmann P, Mariotte S, Naas T, Labia R, Nicolas MH. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrobial Agents and Chemotherapy. 37: 939-946. DOI: 10.1128/Aac.37.5.939  0.464
Show low-probability matches.